Prevalence and clinical correlates of abnormal lipid metabolism in older Chinese patients with first-episode drug-naïve major depressive disorder.
Abnormal lipid metabolism
Clinical correlates
Major depressive disorder patients
Prevalence
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
received:
26
12
2023
accepted:
15
07
2024
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
epublish
Résumé
Older major depressive disorder (MDD) patients have more complex clinical symptoms and higher abnormal lipid metabolism (ALM) rates. This study aimed to compare clinical differences between those with and without ALM in a sample of older first-episode drug naïve (FEDN) patients. We recruited 266 older MDD patients. Socio-demographic variables, clinical data, and lipid parameters were obtained. The Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), and the positive subscale of the Positive and Negative Syndrome Scale (PANSS-P) were conducted to evaluate patients' depression, anxiety and psychotic symptoms, respectively. In this study, we found that the prevalence of comorbid ALM was 86.1% in older MDD patients. Compared with the non-abnormal lipid metabolism (NALM) group, the ALM group had a higher duration of illness, higher clinical global impression of severity scale (CGI-S) and HAMD scores, higher thyroid stimulating hormone (TSH) and glucose levels. Logistic regression analysis indicated that duration of illness (OR = 1.11, P = 0.023, 95%CI = 1.015-1.216) and CGI-S score (OR = 2.28, P = 0.014, 95%CI = 1.18-4.39) were associated with ALM in older MDD patients. The importance of regular lipid assessment in older MDD patients needs to be taken into account.
Sections du résumé
BACKGROUND
BACKGROUND
Older major depressive disorder (MDD) patients have more complex clinical symptoms and higher abnormal lipid metabolism (ALM) rates. This study aimed to compare clinical differences between those with and without ALM in a sample of older first-episode drug naïve (FEDN) patients.
METHODS
METHODS
We recruited 266 older MDD patients. Socio-demographic variables, clinical data, and lipid parameters were obtained. The Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), and the positive subscale of the Positive and Negative Syndrome Scale (PANSS-P) were conducted to evaluate patients' depression, anxiety and psychotic symptoms, respectively.
RESULTS
RESULTS
In this study, we found that the prevalence of comorbid ALM was 86.1% in older MDD patients. Compared with the non-abnormal lipid metabolism (NALM) group, the ALM group had a higher duration of illness, higher clinical global impression of severity scale (CGI-S) and HAMD scores, higher thyroid stimulating hormone (TSH) and glucose levels. Logistic regression analysis indicated that duration of illness (OR = 1.11, P = 0.023, 95%CI = 1.015-1.216) and CGI-S score (OR = 2.28, P = 0.014, 95%CI = 1.18-4.39) were associated with ALM in older MDD patients.
CONCLUSION
CONCLUSIONS
The importance of regular lipid assessment in older MDD patients needs to be taken into account.
Identifiants
pubmed: 39054520
doi: 10.1186/s12888-024-05967-x
pii: 10.1186/s12888-024-05967-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
534Informations de copyright
© 2024. The Author(s).
Références
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lépine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90. https://doi.org/10.1186/1741-7015-9-90 .
doi: 10.1186/1741-7015-9-90
pubmed: 21791035
pmcid: 3163615
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. https://doi.org/10.1016/S0140-6736(15)60692-4 .
doi: 10.1016/S0140-6736(15)60692-4
pmcid: 4561509
Abdoli N, Salari N, Darvishi N, Jafarpour S, Solaymani M, Mohammadi M, Shohaimi S. The global prevalence of major depressive disorder (MDD) among the elderly: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;132:1067–73. https://doi.org/10.1016/j.neubiorev.2021.10.041 .
doi: 10.1016/j.neubiorev.2021.10.041
pubmed: 34742925
Sousa S, Paúl C, Teixeira L. Predictors of major depressive disorder in older people. Int J Environ Res Public Health. 2021;18(22):11894. https://doi.org/10.3390/ijerph182211894 .
doi: 10.3390/ijerph182211894
pubmed: 34831649
pmcid: 8624368
Jiang CH, Zhu F, Qin TT. Relationships between Chronic diseases and Depression among Middle-aged and Elderly people in China: a prospective study from CHARLS. Curr Med Sci. 2020;40(5):858–70. https://doi.org/10.1007/s11596-020-2270-5 .
doi: 10.1007/s11596-020-2270-5
pubmed: 33123901
Casey DA. Depression in older adults: a Treatable Medical Condition. Prim Care. 2017;44(3):499–510. https://doi.org/10.1016/j.pop.2017.04.007 .
doi: 10.1016/j.pop.2017.04.007
pubmed: 28797375
Miebach L, Wolfsgruber S, Frommann I, Buckley R, Wagner M. Different cognitive complaint profiles in memory clinic and depressive patients. Am J Geriatr Psychiatry. 2018;26(4):463–75. https://doi.org/10.1016/j.jagp.2017.10.018 .
doi: 10.1016/j.jagp.2017.10.018
pubmed: 29224729
Ko SH, Jung Y. Energy Metabolism Changes and dysregulated lipid metabolism in Postmenopausal Women. Nutrients. 2021;13(12):4556. https://doi.org/10.3390/nu13124556 .
doi: 10.3390/nu13124556
pubmed: 34960109
pmcid: 8704126
Pinto B, Conde T, Domingues I, Domingues MR. Adaptation of lipid profiling in Depression Disease and Treatment: a critical review. Int J Mol Sci. 2022;23(4):2032. https://doi.org/10.3390/ijms23042032 .
doi: 10.3390/ijms23042032
pubmed: 35216147
pmcid: 8874755
Enko D, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, Meinitzer A, Kriegshäuser G. Prospective plasma lipid profiling in individuals with and without depression. Lipids Health Dis. 2018;17(1):149. https://doi.org/10.1186/s12944-018-0796-3 .
doi: 10.1186/s12944-018-0796-3
pubmed: 29945617
pmcid: 6020392
Zhang T, Guo L, Li R, Wang F, Yang WM, Yang JB, Cui ZQ, Zhou CH, Chen YH, Yu H, Peng ZW, Tan QR. Alterations of plasma lipids in Adult Women with Major Depressive Disorder and Bipolar Depression. Front Psychiatry. 2022;13:927817. https://doi.org/10.3389/fpsyt.2022.927817 .
doi: 10.3389/fpsyt.2022.927817
pubmed: 35923457
pmcid: 9339614
Vogelzangs N, Comijs HC, Oude Voshaar RC, Stek ML, Penninx BW. Late-life depression symptom profiles are differentially associated with immunometabolic functioning. Brain Behav Immun. 2014;41:109–15. https://doi.org/10.1016/j.bbi.2014.05.004 .
doi: 10.1016/j.bbi.2014.05.004
pubmed: 24838021
Mulvahill JS, Nicol GE, Dixon D, Lenze EJ, Karp JF, Reynolds CF 3rd, Blumberger DM, Mulsant BH. Effect of metabolic syndrome on late-life depression: associations with Disease Severity and Treatment Resistance. J Am Geriatr Soc. 2017;65(12):2651–8. https://doi.org/10.1111/jgs.15129 .
doi: 10.1111/jgs.15129
pubmed: 29235659
pmcid: 5730877
Skoog I, Waern M, Duberstein P, Blennow K, Zetterberg H, Börjesson-Hanson A, Östling S, Guo X, Kern J, Gustafson D, Gudmundsson P, Marlow T, Kern S. A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden. Biol Psychiatry. 2015;78(10):730–6. https://doi.org/10.1016/j.biopsych.2015.01.006 .
doi: 10.1016/j.biopsych.2015.01.006
pubmed: 25708227
Zhang J, Lin L, Dai X, Xiao N, Ye Q, Chen X. ApoE4 increases susceptibility to stress-induced age-dependent depression-like behavior and cognitive impairment. J Psychiatr Res. 2021;143:292–301. https://doi.org/10.1016/j.jpsychires.2021.09.029 .
doi: 10.1016/j.jpsychires.2021.09.029
pubmed: 34530340
Hickie I, Scott E, Naismith S, Ward PB, Turner K, Parker G, Mitchell P, Wilhelm K. Late-onset depression: genetic, vascular and clinical contributions. Psychol Med. 2001;31(8):1403–12. https://doi.org/10.1017/s0033291701004731 .
doi: 10.1017/s0033291701004731
pubmed: 11722155
HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. https://doi.org/10.1136/jnnp.23.1.56 .
doi: 10.1136/jnnp.23.1.56
pubmed: 14399272
pmcid: 495331
HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–5. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x .
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76. https://doi.org/10.1093/schbul/13.2.261 .
doi: 10.1093/schbul/13.2.261
pubmed: 3616518
Joiner TE Jr, Steer RA, Brown G, Beck AT, Pettit JW, Rudd MD. Worst-point suicidal plans: a dimension of suicidality predictive of past suicide attempts and eventual death by suicide. Behav Res Ther. 2003;41(12):1469–80. https://doi.org/10.1016/s0005-7967(03)00070-6 .
doi: 10.1016/s0005-7967(03)00070-6
pubmed: 14583414
Liu Y, Kong X, Wang W, Fan F, Zhang Y, Zhao M, Wang Y, Wang Y, Wang Y, Qin X, Tang G, Wang B, Xu X, Hou FF, Gao W, Sun N, Li J, Venners SA, Jiang S, Huo Y. Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention Trial. J Lipid Res. 2017;58(1):256–66. https://doi.org/10.1194/jlr.P067686 .
doi: 10.1194/jlr.P067686
pubmed: 27879312
Hu J, Ji Y, Lang X, Zhang XY. Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study. J Psychiatr Res. 2023;163:55–62. https://doi.org/10.1016/j.jpsychires.2023.05.016 .
doi: 10.1016/j.jpsychires.2023.05.016
pubmed: 37201238
Blank K, Szarek BL, Goethe JW. Metabolic abnormalities in adult and geriatric major depression with and without comorbid dementia. J Clin Hypertens (Greenwich). 2010;12(6):456–61. https://doi.org/10.1111/j.1751-7176.2010.00293.x .
doi: 10.1111/j.1751-7176.2010.00293.x
pubmed: 20591094
de Wit AE, Giltay EJ, de Boer MK, Bosker FJ, van der Mast RC, Comijs HC, Oude Voshaar RC, Schoevers RA. Associations between testosterone and metabolic syndrome in depressed and non-depressed older men and women. Int J Geriatr Psychiatry. 2019;34(3):463–71. https://doi.org/10.1002/gps.5040 .
doi: 10.1002/gps.5040
pubmed: 30474223
pmcid: 6590367
Macías-Cortés ED, Llanes-González L, Aguilar-Faisal L, Asbun-Bojalil J. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP study. Homeopathy. 2017;106(1):3–10. https://doi.org/10.1016/j.homp.2016.11.002 .
doi: 10.1016/j.homp.2016.11.002
pubmed: 28325221
Kumar A, Narayanaswamy JC, Venkatasubramanian G, Raguram R, Grover S, Aswath M. Prevalence of metabolic syndrome and its clinical correlates among patients with bipolar disorder. Asian J Psychiatr. 2017;26:109–14. https://doi.org/10.1016/j.ajp.2017.01.020 .
doi: 10.1016/j.ajp.2017.01.020
pubmed: 28483070
Bachen EA, Muldoon MF, Matthews KA, Manuck SB. Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress. Psychosom Med. 2002;64(4):587–94. https://doi.org/10.1097/01.psy.0000021943.35402.8a .
doi: 10.1097/01.psy.0000021943.35402.8a
pubmed: 12140348
Delarue J, LeFoll C, Corporeau C, Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev. 2004;44(3):289–99. https://doi.org/10.1051/rnd:2004033 .
doi: 10.1051/rnd:2004033
pubmed: 15460168
Scola G, Versace A, Metherel AH, Monsalve-Castro LA, Phillips ML, Bazinet RP, Andreazza AC. Alterations in peripheral fatty acid composition in bipolar and unipolar depression. J Affect Disord. 2018;233:86–91. https://doi.org/10.1016/j.jad.2017.12.025 .
doi: 10.1016/j.jad.2017.12.025
pubmed: 29336895
Lappin JM, Morgan KD, Morgan C, Dazzan P, Reichenberg A, Zanelli JW, Fearon P, Jones PB, Lloyd T, Tarrant J, Farrant A, Leff J, Murray RM. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr Res. 2007;95(1–3):103–10. https://doi.org/10.1016/j.schres.2007.05.037 .
doi: 10.1016/j.schres.2007.05.037
pubmed: 17644343
Walczak K, Sieminska L. Obesity and thyroid Axis. Int J Environ Res Public Health. 2021;18(18):9434. https://doi.org/10.3390/ijerph18189434 .
doi: 10.3390/ijerph18189434
pubmed: 34574358
pmcid: 8467528
Baek JH, Kang ES, Fava M, et al. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. J Affect Disord. 2014;169:112–7. https://doi.org/10.1016/j.jad.2014.08.009 .
doi: 10.1016/j.jad.2014.08.009
pubmed: 25189990
Sarwar H, Rafiqi SI, Ahmad S, et al. Hyperinsulinemia Associated Depression. Clin Med Insights Endocrinol Diabetes. 2022;15:11795514221090244. https://doi.org/10.1177/11795514221090244 . Published 2022 Apr 21.
doi: 10.1177/11795514221090244
pubmed: 35494421
pmcid: 9039439
Li L, Shelton RC, Chassan RA, Hammond JC, Gower BA, Garvey TW. Impact of major depressive disorder on Prediabetes by impairing insulin sensitivity. J Diabetes Metab. 2016;7(4):664. https://doi.org/10.4172/2155-6156.1000664 .
doi: 10.4172/2155-6156.1000664
pubmed: 27274905
pmcid: 4892179
Zhang Y, He JR, Liang HB, Lu WJ, Yang GY, Liu JR, Zeng LL. Diabetes mellitus is associated with late-onset post-stroke depression. J Affect Disord. 2017;221:222–6. https://doi.org/10.1016/j.jad.2017.06.045 .
doi: 10.1016/j.jad.2017.06.045
pubmed: 28654846
O’Flaherty B, Neigh GN, Rainnie D. High-fructose diet initiated during adolescence does not affect basolateral amygdala excitability or affective-like behavior in Sprague Dawley rats. Behav Brain Res. 2019;365:17–25. https://doi.org/10.1016/j.bbr.2019.02.042 .
doi: 10.1016/j.bbr.2019.02.042
pubmed: 30807811
pmcid: 6550332